Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pacific Hospital Supply Co., Ltd. (4126:TWSE), powered by AI.
Pacific Hospital Supply Co., Ltd. is currently trading at $80.60. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Pacific Hospital Supply Co., Ltd. on Alpha Lenz.
Pacific Hospital Supply Co., Ltd.'s P/E ratio is 15.3.
“Pacific Hospital Supply Co., Ltd. trades at a P/E of 15.3 (fair value) with solid ROE of 13.0%.”
Ask for details →Pacific Hospital Supply Co., Ltd. is a prominent manufacturer and supplier of medical devices and disposable healthcare products. Founded in 1977 and headquartered in Miaoli, Taiwan, the company specializes in providing **disposable medical supplies**, medical equipment, and comprehensive **centralized medicinal gas piping systems** for hospitals and healthcare institutions. Its product portfolio includes items such as tubing, drainage systems, respiratory therapy products, gas outlets, and operating theatre equipment. Pacific Hospital Supply Co., Ltd. is recognized for its rigorous quality standards, with facilities certified under GMP and ISO 13485, and most products meeting CE certification requirements. The company serves the healthcare sector both domestically and internationally, exporting over 600 products to more than 80 countries and regions. Through a commitment to innovation, strict production controls, and professional service, Pacific Hospital Supply Co., Ltd. plays a significant role in supporting the efficiency, safety, and performance of healthcare systems worldwide by supplying essential medical technologies and single-use products.
“Pacific Hospital Supply Co., Ltd. trades at a P/E of 15.3 (fair value) with solid ROE of 13.0%.”
Ask for details →Pacific Hospital Supply Co., Ltd. (ticker: 4126) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 807 employees. Market cap is $5.9B.
The current price is 80.6 with a P/E ratio of 15.28x and P/B of 1.97x.
ROE is 12.96% and operating margin is 19.67%. Annual revenue is $2.4B.